Henry Repeating Arms, one of America's leading firearms manufacturers, is building upon the success of its now sold-out and ...

GRAIL, Inc. , a healthcare company whose mission is to detect cancer early when it can be cured, today announced that positive performance and safety results from its registrational PATHFINDER 2 study ...

Dana Incorporated will release its 2025 third-quarter financial results on Wednesday, October 29, 2025. A press release will be issued at approximately 7 a.m. EDT, followed by a conference call and ...

Gibraltar Industries, Inc. , a leading manufacturer and provider of products and services for the residential, agtech and infrastructure markets, announced today that it expects to release its third ...

AlphaGen Intelligence Corp. ("AlphaGen" or the "Company") announces that it has closed its previously announced non-brokered private placement financing (the "Offering") by issuing a total of ...

Northeast Recovery LLC ("Northeast Recovery") today announced that it has completed a debt-for-assets transaction with Ark National Holdings LLC ("Ark Behavioral Health"), a leading provider of ...

MDA Space Ltd. , a trusted mission partner to the rapidly expanding global space industry, today announced that it will release its third quarter 2025 financial results before market open on Friday, ...

OverActive Media Corp. ("OverActive" or the "Company") a global esports, digital media and entertainment company for today's generation of fans, today announced an upsizing of the previously announced ...

Bridgeway Lending Partners LLC d/b/a LenderMAC ("LenderMAC" or the "Company") today announced it has entered into a strategic relationship with Ares Alternative Credit funds ("Ares") in the form of a ...

Latham & Watkins LLP1 is pleased to announce that three prominent restructuring partners ? Ryan Preston Dahl, Benjamin M. Rhode, and Natasha Hwangpo ?  will join the firm. The highly accomplished ...

The Tribunal issued a Notice of Hearing on October 17, 2025 setting the matter down to be heard on November 5, 2025 at 2:00 p.m. or as soon thereafter as the hearing can be held in the above-named ...

Amgen and AstraZeneca today announced that the U.S. Food and Drug Administration (FDA) approved TEZSPIRE® (tezepelumab-ekko) for the add-on maintenance treatment of inadequately controlled chronic ...